In what would be a classic example of the importance of bottoms-up stock picking, 10 pharma stocks have posted more than 100 percent returns even as the pharma index has been the worst-hit.
Shares of the pharmaceutical sector have come in for a bit of stick from investors over the past couple of years following a spate of quality concerns that have hit companies.
Widely considered as a "defensive", shares of pharma companies are usually more resilient to sharp declines but despite this, the BSE Healthcare index fell has fallen as much as 11.75 percent in the past one year, making it the worst-performing sector index.
However, in what would be a classic example of the importance of bottoms-up stock picking, data shows that over the same period, 10 stocks have moved against the grain and posted more than 100 percent returns.
Medicamen Biotec topped the list with 686 percent gains in last one year.